177 related articles for article (PubMed ID: 24098812)
1. Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors.
Narendran R; Himes M; Mason NS
PLoS One; 2013; 8(9):e76905. PubMed ID: 24098812
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
Narendran R; Mason NS; May MA; Chen CM; Kendro S; Ridler K; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
Synapse; 2011 Jan; 65(1):35-40. PubMed ID: 20506186
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
Narendran R; Mason NS; Chen CM; Himes M; Keating P; May MA; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
Synapse; 2011 Oct; 65(10):991-7. PubMed ID: 21360596
[TBL] [Abstract][Full Text] [Related]
5. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
Frankle WG; Mason NS; Rabiner EA; Ridler K; May MA; Asmonga D; Chen CM; Kendro S; Cooper TB; Mathis CA; Narendran R
Synapse; 2010 Dec; 64(12):879-85. PubMed ID: 20506387
[TBL] [Abstract][Full Text] [Related]
6. Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457--a test-retest analysis.
Vilkman H; Kajander J; Någren K; Oikonen V; Syvälahti E; Hietala J
Eur J Nucl Med; 2000 Nov; 27(11):1666-73. PubMed ID: 11105823
[TBL] [Abstract][Full Text] [Related]
7. Reference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PET.
Sandiego CM; Gallezot JD; Lim K; Ropchan J; Lin SF; Gao H; Morris ED; Cosgrove KP
J Cereb Blood Flow Metab; 2015 Mar; 35(4):623-9. PubMed ID: 25564239
[TBL] [Abstract][Full Text] [Related]
8. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
Aalto S; Hirvonen J; Kaasinen V; Hagelberg N; Kajander J; Någren K; Seppälä T; Rinne JO; Scheinin H; Hietala J
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):475-83. PubMed ID: 18985345
[TBL] [Abstract][Full Text] [Related]
9. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
[TBL] [Abstract][Full Text] [Related]
10. Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.
Narendran R; Jedema HP; Lopresti BJ; Mason NS; Gurnsey K; Ruszkiewicz J; Chen CM; Deuitch L; Frankle WG; Bradberry CW
Mol Psychiatry; 2014 Mar; 19(3):302-10. PubMed ID: 23439486
[TBL] [Abstract][Full Text] [Related]
11. Failure to detect amphetamine-induced dopamine release in the cortex with [
Gertler J; Tollefson S; Jordan R; Himes ML; Mason NS; Frankle WG; Narendran R
Synapse; 2018 Sep; 72(9):e22037. PubMed ID: 29876970
[TBL] [Abstract][Full Text] [Related]
12. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
Asselin MC; Montgomery AJ; Grasby PM; Hume SP
J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
[TBL] [Abstract][Full Text] [Related]
13. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
Chou YH; Halldin C; Farde L
Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions.
Sudo Y; Suhara T; Inoue M; Ito H; Suzuki K; Saijo T; Halldin C; Farde L
Nucl Med Commun; 2001 Nov; 22(11):1215-21. PubMed ID: 11606887
[TBL] [Abstract][Full Text] [Related]
15. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
Hagelberg N; Aalto S; Kajander J; Oikonen V; Hinkka S; Någren K; Hietala J; Scheinin H
Pain; 2004 May; 109(1-2):86-93. PubMed ID: 15082129
[TBL] [Abstract][Full Text] [Related]
16. Low convergent validity of [
Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Neuroimage; 2021 Feb; 226():117523. PubMed ID: 33144221
[TBL] [Abstract][Full Text] [Related]
17. Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain.
Ito H; Sudo Y; Suhara T; Okubo Y; Halldin C; Farde L
Neuroimage; 2001 Mar; 13(3):531-9. PubMed ID: 11170818
[TBL] [Abstract][Full Text] [Related]
18. Imaging Cortical Dopamine Transmission in Cocaine Dependence: A [
Narendran R; Mason NS; Himes ML; Frankle WG
Biol Psychiatry; 2020 Nov; 88(10):788-796. PubMed ID: 32507390
[TBL] [Abstract][Full Text] [Related]
19. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
[TBL] [Abstract][Full Text] [Related]
20. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
